AlphaFold predicted structure
SLC39A7 · Q92504

Mean pLDDT
66.2/ 100
Low
469 residues
Confidence breakdown
- Very high(≥ 90)21%
- Confident(70–90)27%
- Low(50–70)13%
- Very low(< 50)39%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
solute carrier family 39 member 7
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalEpidermolysis bullosa and congenital skin fragility
agammaglobulinemia 9, autosomal recessive
agammaglobulinemia
B cell deficiency
neurodegenerative disease
Alzheimer disease
lysosomal storage disease
multiple sclerosis
Parkinson disease
breast cancer
type 2 diabetes mellitus
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Zinc transporter SLC39A7
Transports Zn(2+) from the endoplasmic reticulum (ER)/Golgi apparatus to the cytosol, playing an essential role in the regulation of cytosolic zinc levels (PubMed:14525538, PubMed:15705588, PubMed:28205653, PubMed:29980658). Acts as a gatekeeper of zinc release from intracellular stores, requiring post-translational activation by phosphorylation, resulting in activation of multiple downstream pathways leading to cell growth and proliferation (PubMed:22317921, PubMed:28205653, PubMed:29980658). Has an essential role in B cell development and is required for proper B cell receptor signaling (PubMed:30718914). Plays an important role in maintaining intestinal epithelial homeostasis and skin dermis development by regulating ER function (By similarity). Controls cell signaling pathways involved in glucose metabolism in skeletal muscle (By similarity). Has a protective role against ER stress in different biological contexts (PubMed:29980658, PubMed:30237509). Mediates Zn(2+)-induced ferroptosis (PubMed:33608508)
SLC39A7 · Q92504

Mean pLDDT
66.2/ 100
Low
469 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0